Affinivax is a clinical stage biotechnology company developing a next generation approach in vaccine technologies to design both preventive and therapeutic vaccines that provide broader protection against infectious and other immune mediated diseases.
Location: United States, Massachusetts, Cambridge
Employees: 51-200
Total raised: $348.5M
Investors 6
| Date | Name | Website |
| 20.02.2021 | Logos Capi... | logoscapit... |
| - | Foresite C... | foresiteca... |
| - | EcoR1 Capi... | ecor1cap.c... |
| - | Perceptive... | perceptive... |
| - | CARB-X | carb-x.org |
| - | Bain Capit... | baincapita... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 08.01.2021 | Series C | $226M | - |
| 24.04.2020 | Series B | $120M | - |
| 05.02.2016 | - | $2.5M | - |
Mentions in press and media 16
| Date | Title | Description | Source |
| 01.06.2022 | Companies that thought turning a profit was hard last year a... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 08.01.2021 | Affinivax Raises $226M in Series C Financing | Affinivax, Inc., a Cambridge, MA-based clinical stage biopharmaceutical company pioneering the devel... | finsmes.co... |
| 08.01.2021 | T. Rowe Price Joins $226 Million Series C for Affinivax | Affinivax, Inc., a clinical stage biopharmaceutical company pioneering the development of a novel cl... | citybizlis... |
| 08.01.2021 | Buoyed by renewed clamor for infectious disease R&D, Aff... | After getting off a meaty $120 million round in April, the height of the first wave of COVID-19 infe... | fiercebiot... |
| 08.01.2021 | Buoyed by renewed clamor for infectious disease R&D, Aff... | After getting off a meaty $120 million round in April, the height of the first wave of COVID-19 infe... | fiercebiot... |
| 08.01.2021 | Daily funding roundup - January 8th, 2021 | SilviaTerra raised $4.4M; Hipcamp landed $57M; DiCE Molecules secured $80M; Affinivax picks up $226M... | vator.tv/n... |
| 08.01.2021 | Affinivax Announces $226 Million Series C Financing | Affinivax, Inc., a clinical stage biopharmaceutical company pioneering the development of a novel cl... | citybizlis... |
| 24.04.2020 | Affinivax Raises $120M to Advance Clinical Trials of Vaccine... | Photo: Shutterstock Affinivax, a biotech startup out of Cambridge, announced Thursday it closed on ... | builtinbos... |
| 23.04.2020 | Affinivax banks $120M to push vaccines against hospital-asso... | Affinivax, the company looking to unseat the world’s best-selling vaccine, has reeled in $120 millio... | fiercebiot... |
| 23.04.2020 | Affinivax Closes On $120M Series B As Biotech Takes Center S... | 6 Shares Email Facebook Twitter LinkedIn Biotech companies have not historically been thought of as... | news.crunc... |
Show more